Trial intelligence / Profile preview

Topical tretinoin for skin quality and collagen changes in diabetes at risk of neuropathic ulceration

2006-005597-43Phase 4Completed

Sponsor
University of Birmingham
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tretinoin in diabetes mellitus (DM) (2 arms), sponsored by University of Birmingham. Primary endpoints: Change in collagen structure and synthesis after topical tretinoin treatment, Change in MMP and TIMP expression after topical tretinoin treatment and 2 more. Started Sep 2007; status: completed.

02

Drugs

tretinoin
03

Conditions

diabetes mellitus (DM)

Beyond the preview

Go deeper on 2006-005597-43.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005597-43.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call